Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
3.080
-0.150 (-4.64%)
At close: Jun 27, 2025, 4:00 PM
3.070
-0.010 (-0.32%)
After-hours: Jun 27, 2025, 7:58 PM EDT
Aptevo Therapeutics Employees
Aptevo Therapeutics had 37 employees as of December 31, 2024. The number of employees decreased by 3 or -7.50% compared to the previous year.
Employees
37
Change (1Y)
-3
Growth (1Y)
-7.50%
Revenue / Employee
n/a
Profits / Employee
-$640,649
Market Cap
11.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
APVO News
- 7 days ago - Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules - Accesswire
- 7 days ago - Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers - Accesswire
- 7 days ago - Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
- 9 days ago - Aptevo More Than Doubles After Favorable Results in Leukemia Study - Market Watch
- 9 days ago - Aptevo Therapeutics Touts Data From Investigational Drug Trial For Aggressive Blood Cancer - Benzinga
- 9 days ago - Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules - Accesswire
- 9 days ago - Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML - Accesswire
- 14 days ago - Aptevo Participating in the BIO International Convention - Accesswire